You are here: Industry Insights > Asthma

News List

Only Four in 10 With Severe Asthma See Specialist drugs
July 01, 2021
Specialist care for severe asthma is underutilized, with fewer than four in 10 patients with severe asthma seeking care, according to a study published online June 17 in the Journal of Allergy and Clinical Immunology: In Practice.
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms firstwordpharma
June 18, 2021
CytoReason today announced the initiation of a project with French global biopharmaceutical company Sanofi, which will utilize its cell-centered models and deconvolution techniques to suggest mechanistic insights for each asthma endotype.
Asthma Flares Down Among Black, Hispanic Patients During Pandemic drugs
June 03, 2021
There was a substantial decrease in asthma exacerbations among Black and Hispanic patients during the COVID-19 pandemic, according to a study recently published in the Journal of Allergy and Clinical Immunology: In Practice.
Americans' Lung Health: The Poor Suffer Most drugs
June 02, 2021
The health of your lungs may have a lot to do with the size of your bank account, a new, large study indicates.
Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA drugs
May 31, 2021
AMGN today announced its partner AZN submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tezepelumab, a potential first-in-class medicine in severe asthma.
Dexpramipexole could be a promising treatment for eosinophilic asthma europeanpharmaceuticalreview
May 20, 2021
Oral doses of dexpramipexole lowered eosinophil counts by up to 80 percent and showed signs of improving lung function in a Phase II eosinophilic asthma trial.
Sanofi’s Dupixent 'rapidly' improves lung function in children pharmatimes
May 18, 2021
Sanofi’s Dupixent significantly reduced severe asthma attacks and rapidly improved lung function in children aged six to 11 years old with uncontrolled moderate-to-severe asthma, according to detailed results from a Phase III trial.
Common asthma drug speeds up Covid-19 recovery at home, study finds pharmaceutical-technology
April 14, 2021
Oxford University researchers have found that a cheap asthma drug can help speed up recovery for people at home with Covid-19.
Low asthma patient adherence shows need for personalised and convenient medicines: GlobalData expresspharma
April 14, 2021
GlobalData has revealed that 80 per cent of asthma patients do not take their medication effectively. The reasons for this poor patient adherence are numerous and can include poor inhaler technique, poor perception, complex regimens and the cost of ...
Inhaled asthma drug accelerates recovery from COVID-19 pharmatimes
April 13, 2021
The inhaled corticosteroid medication budesonide, widely used for the treatment of asthma, has been found to aid the recovery of COVID-19 patients when administered at home.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page